Cargando…
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
The endocannabinoid system (ECS) is ubiquitous in most human tissues, and involved in the regulation of mental health. Consequently, its dysregulation is associated with neuropsychiatric and neurodegenerative disorders. Together, the ECS and the expanded endocannabinoidome (eCBome) are composed of g...
Autores principales: | Kibret, Berhanu Geresu, Ishiguro, Hiroki, Horiuchi, Yasue, Onaivi, Emmanuel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778243/ https://www.ncbi.nlm.nih.gov/pubmed/35055161 http://dx.doi.org/10.3390/ijms23020975 |
Ejemplares similares
-
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022) -
Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2018) -
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS
por: Onaivi, E.S
Publicado: (2011) -
Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
por: Liu, Qing-Rong, et al.
Publicado: (2020) -
Involvement of CB2 Receptors in the Neurobehavioral Effects of Catha Edulis (Vahl) Endl. (Khat) in Mice
por: Geresu, Berhanu, et al.
Publicado: (2019)